Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Astera Labs Sees Q4 Adj EPS $0.50-$0.51 vs $0.42 Est

Author: Benzinga Newsdesk | November 04, 2025 04:10pm
RECONCILIATION OF GAAP TO NON-GAAP OUTLOOK (Unaudited)

(In millions, except percentages and per share amounts)

 
Outlook for Three Months Ending

December 31, 2025
LowHigh
GAAP gross margin75%75%
Stock-based compensation expense  
Non-GAAP gross margin75%75%
GAAP operating expense$129$134
Stock-based compensation expense4444  
Non-GAAP operating expense$85$90
GAAP tax rate45%45%
Income tax effect(30)(30)
Non-GAAP tax rate15%15%
GAAP EPS - diluted$0.20$0.20
Stock-based compensation expense and income tax effect0.310.31  
Non-GAAP EPS - diluted$0.51$0.51


 

Posted In: ALAB

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist